Phaeoacremonium sphinctrophorum as a Novel Agent of Eumycetoma

Ahmed, Sarah-Abdalla; De-Hoog, G. S.; Bustamante Rufino, Ana Beatriz; Van-De-Sande, Wendy-W. J.; Seas Ramos, Carlos Rafael

dc.contributor.author	Bustamante Rufino, Ana Beatriz
dc.contributor.author	Ahmed, Sarah-Abdalla
dc.contributor.author	De-Hoog, G. S.
dc.contributor.author	Seas Ramos, Carlos Rafael
dc.contributor.author	Van-De-Sande, Wendy-W. J.
dc.date.accessioned	2019-02-06T14:51:17Z
dc.date.available	2019-02-06T14:51:17Z
dc.date.issued	2016
dc.identifier.uri	https://hdl.handle.net/20.500.12866/5195
dc.description.abstract	Eumycetoma is a chronic granulomatous fungal disease of the subcutaneous tissues characterized by large tumorous masses and the production either black or white grains. As a result of the use of molecular diagnostic techniques, previously unrecognized causative agents of eumycetoma have been discovered. We report the first case to our knowledge of eumycetoma caused by Phaeoacremonium sphinctrophorum...	en_US
dc.language.iso	eng
dc.publisher	American Medical Association
dc.relation.ispartofseries	JAMA Dermatology
dc.rights	info:eu-repo/semantics/restrictedAccess
dc.rights.uri	https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject	Adult	en_US
dc.subject	Antifungal Agents/therapeutic use	en_US
dc.subject	Ascomycota/isolation & purification	en_US
dc.subject	Biopsy, Needle	en_US
dc.subject	Follow-Up Studies	en_US
dc.subject	Foot Dermatoses/drug therapy/microbiology/pathology	en_US
dc.subject	Humans	en_US
dc.subject	Immunohistochemistry	en_US
dc.subject	Itraconazole/therapeutic use	en_US
dc.subject	Male	en_US
dc.subject	Mycetoma/diagnosis/drug therapy/pathology	en_US
dc.subject	Severity of Illness Index	en_US
dc.subject	Treatment Outcome	en_US
dc.title	Phaeoacremonium sphinctrophorum as a Novel Agent of Eumycetoma	en_US
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	https://doi.org/10.1001/jamadermatol.2016.1310
dc.subject.ocde	https://purl.org/pe-repo/ocde/ford#3.02.15
dc.relation.issn	2168-6084